After completing his Master’s degree in Chemistry at Western Kentucky University, Dr. Hitesh Kumar Waghwani pursued a research-focused academic journey at Indiana University Bloomington. Under Prof. Trevor Douglas, he explored the design and development of bio-inspired nanomaterials. Transitioning to the biotech industry at Affinivax Inc, now acquired by Glaxosmithkline Vaccines, he continued his research-centric approach with the aim of advancing global health. As an Expert Scientist in Technical R&D, he leads projects in process scale-up and technology transfer while supporting clinical trials across Phases I-III.